Evisceration and enucleation strongly linked to ocular injuries from IEDs

Article

Ocular injuries caused by improvised explosive devices (IEDs) are strongly associated with severe ocular damage repaired by evisceration or enucleation.

Ocular injuries caused by improvised explosive devices (IEDs) are strongly associated with severe ocular damage repaired by evisceration or enucleation, states an investigation published in Eye.

Dr F.C. Erdurman et al., Department of Ophthalmology, Gulhane Military Medical Academy and School of Medicine, Ankara, Turkey, conducted a retrospective review of 61 eyes of 39 patients who had suffered from ocular injuries caused by IEDs. The average patient age was 24 years and the average follow-up was 6 months. Of the patients studied, 49 eyes had open-globe injuries and 12 eyes had closed-globe injuries.

The results showed that eyes with open-globe injury experienced a higher rate of intraocular foreign body (IOFB) injury with 76% of eyes presenting with it. Evisceration or enucleation as a primary surgical intervention was needed in 28% of eyes and 36% of eyes presented with no light perception.

At the final follow-up 43% of eyes demonstrated no light perception. In eyes that underwent vitreoretinal surgery 50% of them developed postoperative proliferative vitreoretinopathy (PVR). Postoperative PVR was identified as the most frequent cause of poor visual outcome.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.